- Home
- EPRX vs ZJYL Comparison
EPRX vs ZJYL Comparison
Compare EPRX & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPRX
- ZJYL
- Stock Information
- Founded
- EPRX 2011
- ZJYL 2006
- Country
- EPRX Canada
- ZJYL China
- Employees
- EPRX N/A
- ZJYL N/A
- Industry
- EPRX
- ZJYL Industrial Specialties
- Sector
- EPRX
- ZJYL Consumer Discretionary
- Exchange
- EPRX NYSE
- ZJYL Nasdaq
- Market Cap
- EPRX 109.7M
- ZJYL 127.4M
- IPO Year
- EPRX N/A
- ZJYL 2023
- Fundamental
- Price
- EPRX $3.65
- ZJYL $0.76
- Analyst Decision
- EPRX Strong Buy
- ZJYL
- Analyst Count
- EPRX 1
- ZJYL 0
- Target Price
- EPRX $9.00
- ZJYL N/A
- AVG Volume (30 Days)
- EPRX 15.8K
- ZJYL 256.9K
- Earning Date
- EPRX 03-04-2025
- ZJYL 01-01-0001
- Dividend Yield
- EPRX N/A
- ZJYL N/A
- EPS Growth
- EPRX N/A
- ZJYL 18.46
- EPS
- EPRX N/A
- ZJYL 0.02
- Revenue
- EPRX N/A
- ZJYL $23,502,010.00
- Revenue This Year
- EPRX N/A
- ZJYL N/A
- Revenue Next Year
- EPRX N/A
- ZJYL N/A
- P/E Ratio
- EPRX N/A
- ZJYL $32.52
- Revenue Growth
- EPRX N/A
- ZJYL 18.57
- 52 Week Low
- EPRX $2.20
- ZJYL $0.70
- 52 Week High
- EPRX $4.08
- ZJYL $11.15
- Technical
- Relative Strength Index (RSI)
- EPRX N/A
- ZJYL 43.01
- Support Level
- EPRX N/A
- ZJYL $0.77
- Resistance Level
- EPRX N/A
- ZJYL $0.90
- Average True Range (ATR)
- EPRX 0.00
- ZJYL 0.09
- MACD
- EPRX 0.00
- ZJYL -0.01
- Stochastic Oscillator
- EPRX 0.00
- ZJYL 1.50
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.